Barclays Maintains an 'Overweight' on Kindred Healthcare (KND); Thoughts on Kindred's Home Health Acquisition
Tweet Send to a Friend
Barclays maintains an 'Overweight' on Kindred Healthcare (NYSE: KND), PT $35.
Barclays analyst says, "Last night, Kindred Healthcare announced that ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Barclays analyst says, "Last night, Kindred Healthcare announced that ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
